Tuesday, January 10, 2017

DF/HCC’s Cancer Care Delivery Research Program

 

Associate Professor Sam W. Lee teaches courses on dermatology at Harvard Medical School in Boston, Massachusetts. Sam W. Lee also serves as a full member of Dana-Farber/Harvard Cancer Center (DF/HCC), which pools together resources of the university’s cancer research community.

At the core of DF/HCC’s work are some of Boston’s medical facilities, namely Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and the Massachusetts General Hospital. The Harvard Medical School and the Harvard T.H. Chan School of Public Health also form part of this comprehensive cancer center. Together with over 1,100 researchers, DF/HCC leads innovative cancer research programs.

DF/HCC heads 18 clinical-based or discipline-based research programs. The Cancer Care Delivery Research Program, a discipline-based program, seeks to improve cancer care by creating cost-effective interventions. It also focuses on eliminating socioeconomic disparities which affect the delivery of cancer treatment. With over 50 investigators, the Cancer Care Delivery Research Program works to ensure the implementation of quality cancer care.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.